Abstract:Background Hepatocellular carcinoma (HCC) is the most common pathological type of liver cancer. Valosin-containing protein (VCP) is a member of the AAA-ATPase family associated with multiple molecular functions and involved in tumor metastasis and prognosis. However, the role of VCP in HCC progression is still unclear. Methods We examined the expression of VCP in HCC using the RNA sequencing and microarray data from public databases and measured it in clinical samples and cell lines by western blot, and immunohistochemistry (IHC). We also evaluated the correlation between VCP and clinical features. The VCP-interacting proteins were identified by co-immunoprecipitation combined with mass spectrometry (CoIP/MS). The underlying molecular mechanisms were investigated using in vitro and in vivo models of HCC. Results We found that VCP expression is significantly increased in tumor tissues and is associated with advanced TNM stages and poorer prognosis in HCC patients. In vitro analyses revealed that VCP overexpression promoted HCC cell proliferation, migration, and invasion via PI3K/AKT/mTOR pathway activation. Conversely, VCP knockdown resulted in the reverse phenotypes. In vivo studies indicated that up-regulated VCP expression accelerated tumor growth in a subcutaneous HCC model. The D1 domain of VCP and A box of HMGB1 were identified as the critical regions for their interaction, and D1 area was required for the tumor-promoting effects induced by VCP expression. VCP enhanced the protein stability of HMGB1 by decreasing its degradation via ubiquitin-proteasome process. Inhibition of HMGB1 markedly attenuated VCP-mediated HCC progression and downstream activation of PI3K/AKT/mTOR signals. Conclusion Collectively, these findings demonstrate that VCP is a potential prognostic biomarker in HCC and exhibits oncogenic roles via PI3K/AKT/mTOR pathway activation. HMGB1 played an essential role in VCP-mediated HCC progression, indicating that VCP and HMGB1 are potential therapeutic targets in human HCC.

High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma

Association of Expression of Valosin Containing Protein with Prognosis of Gastric Carcinoma

Increased Expression of Valosin-Containing Protein (p97) Is Correlated With Disease Recurrence in Follicular Thyroid Cancer

Expression Analysis of VPS72 and Associated Biological Behaviors in Colon Cancer

Overexpression of VCAM-1 is correlated with poor survival of patients with breast cancer

VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients.

VCP Interaction with HMGB1 Promotes Hepatocellular Carcinoma Progression by Activating the PI3K/AKT/mTOR Pathway

The Relationship of VEGF C Expression and Prognosis of Bladder Transitional Cell Carcinoma

Increased Levels of Laptm4b, Vegf and Survivin Are Correlated with Tumor Progression and Poor Prognosis in Breast Cancer Patients

Pre-B-Cell Leukemia Transcription Factor 1 Regulates Expression of Valosin-Containing Protein, a Gene Involved in Cancer Growth

Vav1 Expression is Increased in Esophageal Squamous Cell Carcinoma and Indicates Poor Prognosis.

E74-like Factor 2 Regulates Valosin-Containing Protein Expression

High VCAM-1 Predicts Poor Prognosis and is Associated with Chemotherapy Resistance in Nasopharyngeal Carcinoma

High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database

High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Significance of E-cadherin, Β-Catenin, and Vimentin Expression As Postoperative Prognosis Indicators in Cervical Squamous Cell Carcinoma

Expression of vimentin in pancreatic carcinoma and its clinical significance

Prognostic Value of MUC1 and its Correlation with Tumor-Infiltrating Immune Cells in Breast Cancer

Clinical signiifcance of ICAM-1 expression and its correlation with prognosis of triple-negative breast cance r

Expression of caveolin-1 in human breast carcinoma

Prognostic Value of Vimentin Is Associated With Immunosuppression in Metastatic Renal Cell Carcinoma